维普期刊资源整合服务平台（V6.5）

103篇 您的检索式：作者名="Samama MM"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Laboratory diagnosis of the thrombophilic state in cancer patients 显示文摘	Gouin- Thibault I Samama MM	1999	Semin Thromb He- most1999，25，2：	1
2	An epidemiologic study of risk factors for deep vein thrombosisin in medical outpatients: the Sirius study显示文摘	Samama MM	2000	Arch Intern Med2000，160，22：	1
3	New antithromboticdrugs:American College of Chest Physicians evidence-basedclinical practice guidelines(8th edition)显示文摘	WEITZ JI HIRSH J SAMAMA MM	2008	Chest2008，133，6：	1
4	New antithrombotic drugs : American College of Chest Physicians evidence-based clin- ical practice guidelines (8th edition) 显示文摘	Weitz JI Hirsh J Samama MM	2008	Chest2008，133，6：	1
5	New antithrombitic drugs:Anti-thrombotic therapy and prevention of thrombosis,9th ed:American college of chest physicians evidence-based clinical practice guidelines显示文摘	Weitz JI Eikelboom JW Samama MM	2012	Chest2012，141，2：	1
6	Laboratory assessmentof rivaroxaban: a review显示文摘	Samama MM Contant G Spiro TE	2013	Thromb J2013，11，1：	1
7	In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux显示文摘	Samama MM Mendell J Guinet C		0，，4：	1
8	A silent killer:exploring the berden of vie in medical Patlents显示文摘	Samama MM	2004	VTE Experts meeting:Belgium2004，23，12：	1
9	New antithrombotic drugs:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘	Weitz JI Eikelboom JW Samama MM	2012	Chest2012，141，21：	1
10	Mechanisms for the antithrombotic activity in man of low molecular weight heparins(LMWH)显示文摘	Baral L Gerotziafas GT	1994	Haemostasis1994，24，2：	1
11	The mechanism of action of rivaroxaban-an oral,direct Factor Xa inhibitor-compared with other anticoagulants显示文摘	Samama MM	2011	Thromb Res2011，127，6：	1
12	A silent killer:exploring the berden of vie in medical patlents显示文摘	Samama MM	2004	VTE Experts meeting: Belgium2004，，：	1
13	An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients:the Sirius Study显示文摘	Samama MM	2000	Arch Intern Med2000，160，：	1
14	Assessment of laboratory assays to measure rivaroxaban-an oral, di- rect factor X a inhibitor显示文摘	Samama MM Martinoli JL LeFlem L	2010	Thromb Haemost2010，103，4：	1
15	New antithrombotic drugs: American College of Chest Physicians Evidence-based Clinical Practice Guidelines(8th edition)显示文摘	Weitz JI Hirsh J Samama MM	2008	Chest2008，133，6：	1
16	The mechanism of action of rivaroxaban--an oral, direct factor Xa inhibito-compared with other anticoagulants 显示文摘	Samama MM	2011	Thromb Res2011，127，6：	1
17	New antithromboticdrugs:American college of chest physicians evidence-based clinical practice guidelines (8th Edition)显示文摘	Weitz JI Hirsh J Samama MM	2008	Chest2008，133，：	1
18	The mechanism of action of rivaroxaban-an oral,direct factor Xa inhibitor-compared with other anticoagulants显示文摘	Samama MM	2011	Thromb Res2011，127，6：	1
19	Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports显示文摘	Aurousseau MH Samama MM Belhassen A	1995	Hum Reprod1995，10，1：	1
20	D-dimer levels,connstitu tional thrombophilia,and venous thrombosis prediction:clinical aspects and implications显示文摘	Samama MM Horellou MH Elalamy L	2005	Semin Vasc Med2005，5，4：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示